Abdominal Candidiasis Is a Hidden Reservoir of Echinocandin Resistance
Authors:
Open Access
- 1 December 2014
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 58 (12) , 7601-7605
Abstract
FKS mutant Candida isolates were recovered from 24% (6/25) of abdominal candidiasis patients exposed to echinocandin. Candida glabrata (29%) and Candida albicans (14%) mutants were identified. Multidrug-resistant bacteria were recovered from 83% of FKS mutant infections. Mutations were associated with prolonged echinocandin exposure ( P = 0.01), breakthrough infections ( P = 0.03), and therapeutic failures despite source control interventions (100%). Abdominal candidiasis is a hidden reservoir for the emergence of echinocandin-resistant Candida .Keywords
This publication has 18 references indexed in Scilit:
- The Presence of an FKS Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrataAntimicrobial Agents and Chemotherapy, 2012
- Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized TrialsClinical Infectious Diseases, 2012
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Candida Peritonitis: An Update on the Latest Research and TreatmentsWorld Journal of Surgery, 2011
- Distribution of micafungin in the tissue fluids of patients with invasive fungal infectionsJournal of Infection and Chemotherapy, 2011
- Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus CriteriaClinical Infectious Diseases, 2008
- In Vitro Susceptibility of Breakthrough Candida Bloodstream Isolates Correlates with Daily and Cumulative Doses of FluconazoleAntimicrobial Agents and Chemotherapy, 2006
- Pharmacodynamics of Caspofungin in a Murine Model of Systemic Candidiasis: Importance of Persistence of Caspofungin in Tissues to Understanding Drug ActivityAntimicrobial Agents and Chemotherapy, 2005
- Disposition of Caspofungin, a Novel Antifungal Agent, in Mice, Rats, Rabbits, and MonkeysAntimicrobial Agents and Chemotherapy, 2004
- Treatment of Candidal Cholangitis with Caspofungin Therapy in a Patient with a Liver Transplant: Documentation of Biliary Excretion of CaspofunginClinical Infectious Diseases, 2004